Hendrik T.J. Mantel, Charles B. Rosen, Julie K. Heimbach, Scott L. Nyberg, Michael B. Ishitani, James C. Andrews, Michael A. McKusick, Michael G. Haddock, Steven R. Alberts, Gregory J. Gores – 27 September 2007 – Liver transplantation after neoadjuvant chemoradiotherapy has emerged as an effective treatment for patients with localized, node‐negative, unresectable hilar cholangiocarcinoma (CCA) or CCA arising in the setting of primary sclerosing cholangitis (PSC).

Gerald S. Lipshutz, Ronald W. Busuttil – 27 September 2007

Timothy J.S. Cross, Charalambos G. Antoniades, Paolo Muiesan, Thawab Al‐Chalabi, Varuna Aluvihare, Kosh Agarwal, Bernard C. Portmann, Mohammed Rela, Nigel D. Heaton, John G. O'Grady, Michael A. Heneghan – 27 September 2007 – With increased demand for liver transplantation (LT), outcomes of older recipients have been subjected to greater scrutiny, as previous studies have demonstrated poorer survival outcomes.

Francesco D'Amico, Alessandro Vitale, Enrico Gringeri, Michele Valmasoni, Amedeo Carraro, Alberto Brolese, Giacomo Zanus, Patrizia Boccagni, Davide Francesco D'Amico, Umberto Cillo – 27 September 2007 – In recent years, an increasing number of suboptimal grafts has been used to reduce the gap between the supply and demand of organs for liver transplantation (LT). In this randomized prospective study, we tested the impact of donor harvesting technique on the posttransplantation outcome of suboptimal donor livers.

James D. Perkins – 27 September 2007

Atul Humar, Kenneth Washburn, Richard Freeman, Carlos V. Paya, Houria Mouas, Emma Alecock, Raymund R. Razonable, PV16000 Study Group – 27 September 2007 – Hepatitis C virus (HCV) has been proposed to have immunomodulatory effects in transplant recipients and may promote herpesvirus reactivation. To assess this, we compared the incidence of herpesvirus reactivation in HCV‐positive and HCV‐negative liver transplant recipients.

S. Simona Jakab, Victor J. Navarro, Beth W. Colombe, Constantine Daskalakis, Steven K. Herrine, Simona Rossi – 27 September 2007 – Human leukocyte antigen (HLA) compatibility has no clinically significant impact in cadaveric liver transplantation. Less is known regarding living‐donor liver transplantation (LDLT). Our prior analysis of the Organ Procurement and Transplantation Network (OPTN) database suggested a higher graft failure rate in patients who underwent LDLT from donors with close HLA match.

James V. Guarrera, Barbara J. Alkofer, Nikki Feirt, Rodrigo Sandoval, Benjamin Samstein, Elton T. Smith, David Marshman, Chris Cogswell, Jason Vannatta, Robert S. Brown, Jean C. Emond, John F. Renz – 27 September 2007

Johannes Hadem – 27 September 2007

Julie Polson, William M. Lee – 27 September 2007